28.12.2015 • News

Azelis Closes Koda Acquisition

Azelis completed its acquisition of US-based Koda Distribution Group (KDG) on Dec. 17 following clearance from the regulatory authorities. The deal was announced in mid-October this year.

KDG is now Azelis Americas, led by CEO and President Frank Bergonzi, the former CEO of KDG. The company will continue to operate in the US and Canada using its existing business model and local brands.

Azelis CEO Dr Hans-Joachim Mueller explained that the primary reason behind KDG’s acquisition was the revenue synergies that exist between the two companies which Azelis intends to exploit. “Going forward we will be focusing on generating fast-paced organic growth by extending our offering to the specific markets we serve. Moreover, we also will selectively pursue acquisition opportunities to complement our portfolio,” Mueller said.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.